These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 35163727)
1. The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes. Luchian I; Goriuc A; Sandu D; Covasa M Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163727 [TBL] [Abstract][Full Text] [Related]
2. Effects of tetracyclines on neutrophil, gingival, and salivary collagenases. A functional and western-blot assessment with special reference to their cellular sources in periodontal diseases. Sorsa T; Ding Y; Salo T; Lauhio A; Teronen O; Ingman T; Ohtani H; Andoh N; Takeha S; Konttinen YT Ann N Y Acad Sci; 1994 Sep; 732():112-31. PubMed ID: 7978785 [TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinases-1, matrix metalloproteinases-1 and -8, and collagenase activity levels in peri-implant crevicular fluid after implantation. Nomura T; Ishii A; Shimizu H; Taguchi N; Yoshie H; Kusakari H; Hara K Clin Oral Implants Res; 2000 Oct; 11(5):430-40. PubMed ID: 11168235 [TBL] [Abstract][Full Text] [Related]
5. Characterization of matrix metalloproteinase (MMP-8 and -9) activities in the saliva and in gingival crevicular fluid of children with Down's syndrome. Halinen S; Sorsa T; Ding Y; Ingman T; Salo T; Konttinen YT; Saari H J Periodontol; 1996 Aug; 67(8):748-54. PubMed ID: 8866313 [TBL] [Abstract][Full Text] [Related]
6. Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome. Tsilingaridis G; Yucel-Lindberg T; Modéer T J Periodontal Res; 2013 Oct; 48(5):553-62. PubMed ID: 23298307 [TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. Mäkelä M; Salo T; Uitto VJ; Larjava H J Dent Res; 1994 Aug; 73(8):1397-406. PubMed ID: 8083435 [TBL] [Abstract][Full Text] [Related]
8. Gingival crevicular fluid levels of matrix metalloproteinases cross-sectionally related to periodontitis and metabolic syndrome in community Koreans. Han DH; Shin HS; Paek D; Kim HD J Clin Periodontol; 2012 Dec; 39(12):1125-31. PubMed ID: 23036163 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers of periodontitis in oral fluids. Rai B; Kharb S; Jain R; Anand SC J Oral Sci; 2008 Mar; 50(1):53-6. PubMed ID: 18403884 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658 [TBL] [Abstract][Full Text] [Related]
11. A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis. Golub LM; Lee HM; Greenwald RA; Ryan ME; Sorsa T; Salo T; Giannobile WV Inflamm Res; 1997 Aug; 46(8):310-9. PubMed ID: 9297576 [TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitors of metalloproteinases level and collagenase activity in gingival crevicular fluid: the relevance to periodontal diseases. Nomura T; Ishii A; Oishi Y; Kohma H; Hara K Oral Dis; 1998 Dec; 4(4):231-40. PubMed ID: 10200701 [TBL] [Abstract][Full Text] [Related]